Truist Financial Maintains Wave Life Sciences(WVE.US) With Buy Rating
Wave Life Sciences Is Maintained at Outperform by Mizuho
WAVE Life Sciences Analyst Ratings
Mizuho Securities Maintains Wave Life Sciences(WVE.US) With Buy Rating, Announces Target Price $22
B.Riley Financial Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $22
A Quick Look at Today's Ratings for Wave Life Sciences(WVE.US), With a Forecast Between $20 to $36
WAVE Life Sciences Analyst Ratings
Wave Life Sciences: Promising Advancements and Strategic Growth Potential Drive Buy Rating
Truist Securities Adjusts Price Target on Wave Life Sciences to $36 From $17, Keeps Buy Rating
B.Riley Financial Maintains Wave Life Sciences(WVE.US) With Buy Rating, Raises Target Price to $22
WAVE Life Sciences Analyst Ratings
H.C. Wainwright Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $22
Truist Financial Maintains Wave Life Sciences(WVE.US) With Buy Rating
Wells Fargo Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $22
Leerink Partners Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $22
Wave Life Sciences Is Maintained at Sector Perform by RBC Capital
WAVE Life Sciences Analyst Ratings
H.C. Wainwright Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $22
Mizuho Securities Maintains Wave Life Sciences(WVE.US) With Buy Rating
Truist Financial Maintains Wave Life Sciences(WVE.US) With Buy Rating